Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02918539 · ClinicalTrials.gov registry record
Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Trials
A clinical trial, sponsored by Avid Radiopharmaceuticals.
- Completed
- Registry status
- 317
- Enrollment target
NCT02918539: Completed study, sponsored by Avid Radiopharmaceuticals.
NCT02918539 is a clinical trial that has completed, run by Avid Radiopharmaceuticals. The registered enrollment target is 317 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02918539 has completed, sponsored by Avid Radiopharmaceuticals.
- COMPLETED
- Registry status
- 317 participants
- Enrollment target
Study Summary
This registry will be used to identify patients who have etiology diagnosed or suspected to be Alzheimer's disease and positive amyloid scans, and have indicated their interest in being contacted for an Eli Lilly and Company (Lilly) Alzheimer's Disease drug research trial.
Primary Outcome
There is no formal hypothesis to test in this registry study. The registry will collect contact information of amyloid positive patients with cognitive impairment who have indicated interest in being contacted for a Lilly AD drug research trial. The primary outcome measure to be reported is the total number of participants in the registry.
Interventions
- DRUG florbetapir F 18 PET scan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 317 participants |
| Start Date | 2016-10 |
| Est. Completion | 2017-10-18 |
What the finished NCT02918539 record still lists
NCT02918539 is an observational study that tracks outcomes without assigning an intervention. The registered 317 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which florbetapir F 18 PET scan is the first listed.
NCT02918539 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02918539 about?
NCT02918539 is a clinical study titled "Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Trials". This registry will be used to identify patients who have etiology diagnosed or suspected to be Alzheimer's disease and positive amyloid scans, and have indicated their interest in being contacted for an Eli Lilly and Company (Lilly) Alzheimer's Disease drug research trial.
What is the current status of trial NCT02918539?
This trial is currently completed. The enrollment target is 317 participants. The study started on 2016-10. Estimated completion is 2017-10-18.
What interventions are being tested in trial NCT02918539?
The interventions under investigation include: florbetapir F 18 PET scan (DRUG).
Who is sponsoring clinical trial NCT02918539?
This trial is sponsored by Avid Radiopharmaceuticals, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04594642 · 317 participants · Phase 1
A Study of AZD0486 in Subjects With B-Cell Non-Hodgkin Lymphoma
- NCT04977453 · 317 participants · Phase 1
GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors
- NCT05137054 · 317 participants · Phase 1
A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Patients With Multiple Myeloma That is Resistant to Current Standard of Care Treatments
- NCT05382754 · 317 participants · NA
Home Apnea Testing in CHildren Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia